Suppr超能文献

单独使用或联合使用釉基质衍生物及双相磷酸钙治疗骨内牙周缺损的四年疗效观察。

Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate.

机构信息

Department of Periodontal and Oral Mucosa Diseases, Medical Academy Bialystok, Bialystok, Poland.

出版信息

Clin Oral Investig. 2012 Aug;16(4):1191-7. doi: 10.1007/s00784-011-0611-2. Epub 2011 Sep 1.

Abstract

The aim of this study was to evaluate the 4-year clinical outcomes following regenerative surgery in intrabony defects with either EMD + BCP or EMD. Twenty-four patients with advanced chronic periodontitis, displaying one-, two-, or three-walled intrabony defect with a probing depth of at least 6 mm, were randomly treated with either EMD + BCP (test) or EMD alone (control). The following clinical parameters were evaluated at baseline, at 1 year and at 4 years after regenerative surgery: plaque index, gingival index, bleeding on probing, probing depth, gingival recession, and clinical attachment level (CAL). The primary outcome variable was CAL. No differences in any of the investigated parameters were observed at baseline between the two groups. The test group demonstrated a mean CAL change from from 10.8 ± 1.6 mm to 7.4 ± 1.6 mm (p < 0.001) and to 7.6 ± 1.7 mm (p < 0.001) at 1 and 4 years, respectively. In the control group, mean CAL changed from 10.4 ± 1.3 at baseline to 6.9 ± 1.0 mm (p < 0.001) at 1 year and 7.2 ± 1.2 mm (p < 0.001) at 4 years. At 4 years, two defects in the test group and three defects in the control group have lost 1 mm of the CAL gained at 1 year. Compared to baseline, at 4 years, a CAL gain of ≥3 mm was measured in 67% of the defects (i.e., in 8 out of 12) in the test group and in 75% of the defects (i.e., in 9 out of 12) in the control group. There were no statistically significant differences in any of the investigated parameters at 1 and at 4 years between the two groups. Within their limits, the present results indicate that: (a) the clinical improvements obtained with both treatments can be maintained over a period of 4 years, and (b) in two- and three-walled intrabony defects, the addition of BCP did not additionally improve the outcomes obtained with EMD alone. In two- and three-walled intrabony defects, the combination of EMD + BCP did not show any advantage over the use of EMD alone.

摘要

本研究旨在评估再生手术后 4 年的临床疗效,比较牙周膜(EMD)+骨再生屏障(BCP)与 EMD 单独应用于治疗骨内缺损的效果。将 24 例患有进展性慢性牙周炎的患者,按单壁、双壁或三壁骨内缺损、探诊深度至少 6mm 随机分为两组,分别接受 EMD+BCP(实验组)或 EMD 单独治疗(对照组)。于基线、1 年和 4 年后评估以下临床参数:菌斑指数、牙龈指数、探诊出血、探诊深度、牙龈退缩和临床附着水平(CAL)。主要观察指标为 CAL。两组间基线时各参数均无差异。实验组 CAL 均值从 10.8±1.6mm 分别改善至 7.4±1.6mm(p<0.001)和 7.6±1.7mm(p<0.001),1 年和 4 年时分别改善至 7.4±1.6mm(p<0.001)和 7.6±1.7mm(p<0.001)。对照组 CAL 均值从基线时的 10.4±1.3mm 改善至 6.9±1.0mm(p<0.001)和 7.2±1.2mm(p<0.001)。4 年后,实验组有 2 个缺损和对照组有 3 个缺损的 CAL 丢失了 1 年时的获得量。与基线相比,实验组 67%(12 个中有 8 个)和对照组 75%(12 个中有 9 个)的缺损在 4 年时 CAL 获得量增加了≥3mm。两组间 1 年和 4 年时各参数均无统计学差异。结果提示:(a)两种治疗方法在 4 年内均能维持临床疗效;(b)在双壁和三壁骨内缺损中,BCP 的添加并不能改善 EMD 单独应用的效果。在双壁和三壁骨内缺损中,EMD+BCP 的联合应用并不优于 EMD 单独应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验